Have a personal or library account? Click to login
Thoughts on Selected Movement Disorder Terminology and a Plea for Clarity Cover

Thoughts on Selected Movement Disorder Terminology and a Plea for Clarity

By: Ruth H. Walker  
Open Access
|Dec 2013

References

  1. GoetzCGChmuraTALanskaDJHistory of chorea: Part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000Mov Disord20011633133810.1002/mds.106611295790
  2. RascolOFabreNBrefel-CourbonCet alDyskinesiasEncyclopedia of Movement Disorders, edKompolitiK.VerhagenL.Academic PressOxford, UK2010350361
  3. WalnOJankovicJAn update on tardive dyskinesia: from phenomenology to treatmentTremor Other Hyperkinet Mov (N Y)20133. pii:tre-03-161-4138-1
  4. MccreadieRGPadmavatiRTharaRet alSpontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-upBr J Psychiatry200218113513710.1192/bjp.181.4.32112151284
  5. MerrillRMLyonJLMatiacoPMTardive and spontaneous dyskinesia incidence in the general populationBMC Psychiatry2013131521310.1186/1471-244X-13-15223714238
  6. PappaSDazzanPSpontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic reviewPsychol Med2009391065107610.1017/S003329170800471619000340
  7. LouisEDThe origins of the term "extrapyramidal" within the context of late nineteenth- and early twentieth-century neurology, neurophysiology and neuropathologyJ Hist Med Allied Sci199348687910.1093/jhmas/48.1.688432971
  8. de Oliveira-SouzaRTovar-MollFThe unbearable lightness of the extrapyramidal systemJ Hist Neurosci20122128029210.1080/0964704X.2011.59565222724489
  9. WilsonSAKProgressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liverBrain19123429550910.1093/brain/34.4.295
  10. CoplanJGuggerJJTasleemHTardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical settingJ Affect Disord201315086887110.1016/j.jad.2013.04.05323726783
  11. SuzukiTWhich rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical reviewPsychopharmacol Bull201144183122506437
DOI: https://doi.org/10.5334/tohm.173 | Journal eISSN: 2160-8288
Language: English
Submitted on: Oct 2, 2013
|
Accepted on: Oct 23, 2013
|
Published on: Dec 16, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2013 Ruth H. Walker, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.